BioPharma Credit Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Market Capitalization	779	769	838	859	1,040	982	Upgrade
Market Cap Growth	7.87%	-8.31%	-2.43%	-17.41%	5.90%	-2.00%	Upgrade
Enterprise Value	769	765	809	806	1,031	892	Upgrade
Last Close Price	0.69	0.66	0.61	0.51	0.54	0.43	Upgrade
PE Ratio	8.19	7.96	8.59	10.09	6.87	15.65	Upgrade
PS Ratio	6.64	6.56	7.00	8.06	5.74	12.80	Upgrade
PB Ratio	0.91	0.90	0.89	0.82	0.94	0.98	Upgrade
P/TBV Ratio	0.91	0.90	0.89	0.82	0.94	0.98	Upgrade
P/OCF Ratio	11.50	11.36	9.38	8.88	6.80	13.79	Upgrade
EV/Sales Ratio	6.59	6.53	6.75	7.56	5.70	11.62	Upgrade
EV/EBIT Ratio	8.00	7.93	8.29	9.46	6.82	14.21	Upgrade
Net Debt / Equity Ratio	-0.01	-0.01	0.00	-0.10	-0.09	-0.07	Upgrade
Asset Turnover	0.13	0.13	0.12	0.10	0.16	0.08	Upgrade
Quick Ratio	3.77	3.77	2.09	9.79	5.34	16.51	Upgrade
Current Ratio	3.77	3.77	2.09	9.79	5.34	16.51	Upgrade
Return on Equity (ROE)	11.14%	11.14%	9.69%	8.10%	13.50%	6.19%	Upgrade
Return on Assets (ROA)	6.85%	6.85%	5.97%	4.98%	8.33%	3.85%	Upgrade
Return on Capital Employed (ROCE)	11.30%	11.30%	10.30%	8.10%	13.60%	6.20%	Upgrade
Earnings Yield	12.40%	12.56%	11.64%	9.91%	14.55%	6.39%	Upgrade
Dividend Yield	10.59%	7.90%	9.14%	10.79%	10.74%	11.90%	Upgrade
Payout Ratio	61.56%	61.56%	89.23%	63.58%	52.52%	113.20%	Upgrade
Buyback Yield / Dilution	6.77%	6.77%	6.65%	4.00%	0.72%	0.00%	Upgrade
Total Shareholder Return	17.35%	14.67%	15.79%	14.80%	11.46%	11.90%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.